Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
-
81
-
82
-
83
WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression.
Published 2024“…<b>C.</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
-
84
-
85
-
86
-
87
-
88
-
89
-
90
SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT).
Published 2017“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
-
91
Spt5 protein is significantly decreased in <i>fog<sup>sk8</sup></i> embryos.
Published 2008“…(C–D) Whole mount immunofluorescence detection of Spt5 in WT and <i>fog<sup>sk8</sup></i> embryos at 24 hpf, showing overall decrease of Spt5 protein in <i>fog<sup>sk8</sup></i> embryos. …”
-
92
-
93
SPL decreases diabetes-induced oxidative stress in GL and PT.
Published 2017“…SPL treatment prevents diabetes-induced increment in O<sub>2</sub><sup>●―</sup> production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
-
94
-
95
-
96
-
97
-
98
-
99
-
100